Nasdaq · CIK 0001468929
NXGL NEXGEL, INC.
Insider trading from SEC Form 4. Last filing Sep 29, 2025. Close $4.02 on Oct 9, 2026, +34% from the 52-week low and 0% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Price and insider trades, last year
NXGLOct 9, 2026 · close 4.02
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at NEXGEL, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Scott Robert Henry director sell | $18k 7,697 shares | -6% | - | |
| 25Weak | Adam R. Levy Chief Executive Officer sell | $9,896 4,000 shares | -1% | - | |
| 3Weak | Scott Robert Henry director sell | $7,704 3,000 shares | -2% | - | |
| 33Weak | Adam R. Levy Chief Executive Officer sell | $9,439 4,000 shares | -1% | - | |
| 33Weak | Adam R. Levy Chief Executive Officer sell | $4,613 2,000 shares | -1% | - | |
| 33Weak | Adam R. Levy Chief Executive Officer sell | $2,220 1,000 shares | -0% | - | |
| 33Weak | Adam R. Levy Chief Executive Officer sell | $2,575 1,000 shares | -0% | - | |
| 3Weak | Scott Robert Henry director sell | $8,062 3,000 shares | -2% | - | |
| 3Weak | Scott Robert Henry director sell | $7,825 3,000 shares | -2% | - | |
| 13Weak | Adam R. Levy Chief Executive Officer sell | $12k 4,000 shares | -1% | - | |
| 0Weak | Scott Robert Henry director sell | $8,621 3,000 shares | -2% | - | |
| 0Weak | Scott Robert Henry director sell | $9,798 3,000 shares | -2% | - | |
| 0Weak | Scott Robert Henry director sell | $10k 3,000 shares | -2% | - | |
| 0Weak | Scott Robert Henry director sell | $14k 3,000 shares | -2% | - | |
| 50Moderate | Adam E Drapczuk III Chief Financial Officer buy | $48k 17,500 shares | +30% | - | |
| 30Weak | Scott Robert Henry director buy | $5,000 1,818 shares | +1% | - | |
| 40Moderate | Adam R. Levy Chief Executive Officer buy | $9,999 3,636 shares | +1% | - | |
| 30Weak | Jerome B Zeldis director buy | $9,999 3,636 shares | +4% | - | |
| 25Weak | John Nachum Stein director buy | $9,999 3,636 shares | +1% | - | |
| 33Weak | steven mark glassman director buy | $25k 9,090 shares | +6% | - |
Transactions
The last 36 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -7,697 | $2.36 | $18k | 121,356 | Sep 29, 2025 |
| Aug 28, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -4,000 | $2.47 | $9,896 | 358,284 | Aug 29, 2025 |
| Jun 25, 2025 | John Nachum Stein director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 25, 2025 | Jerome B Zeldis director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 25, 2025 | steven mark glassman director | AGrant or award Stock Option(Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 25, 2025 | Scott Robert Henry director | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 25, 2025 | Scott Robert Henry director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Jun 27, 2025 |
| Jun 25, 2025 | steven mark glassman director | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 5,000 | Jun 27, 2025 |
| Jun 13, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $2.57 | $7,704 | 129,053 | Jun 16, 2025 |
| Jun 9, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -2,000 | $2.33 | $4,659 | 364,284 | Jun 11, 2025 |
| Jun 11, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -2,000 | $2.39 | $4,780 | 362,284 | Jun 11, 2025 |
| Jun 4, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -1,000 | $2.29 | $2,290 | 367,284 | Jun 6, 2025 |
| Jun 5, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -1,000 | $2.32 | $2,323 | 366,284 | Jun 6, 2025 |
| May 30, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -1,000 | $2.22 | $2,220 | 368,284 | Jun 2, 2025 |
| May 16, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock | -1,000 | $2.58 | $2,575 | 369,284 | May 20, 2025 |
| May 12, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $2.69 | $8,062 | 132,053 | May 13, 2025 |
| Apr 10, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $2.61 | $7,825 | 135,053 | Apr 14, 2025 |
| Apr 1, 2025 | Adam R. Levy Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -4,000 | $3.01 | $12k | 370,284 | Apr 2, 2025 |
| Mar 10, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $2.87 | $8,621 | 138,053 | Mar 11, 2025 |
| Feb 10, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $3.27 | $9,798 | 138,553 | Feb 12, 2025 |
| Feb 12, 2025 | Scott Robert Henry director | AGrant or award Common Stock10b5-1 | +2,500 | $0.00 | $0 | 141,053 | Feb 12, 2025 |
| Jan 7, 2025 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $3.37 | $10k | 141,553 | Jan 8, 2025 |
| Dec 20, 2024 | Scott Robert Henry director | SOpen-market sale Common Stock10b5-1 | -3,000 | $4.64 | $14k | 144,553 | Dec 23, 2024 |
| Nov 7, 2024 | John Nachum Stein director | GGift Common Stock | -4,000 | $0.00 | $0 | 467,820 | Nov 22, 2024 |
| Nov 20, 2024 | steven mark glassman director | POpen-market purchase Common Stock | +9,090 | $2.75 | $25k | 154,155 | Nov 22, 2024 |
| Nov 20, 2024 | Jerome B Zeldis director | POpen-market purchase Common Stock | +3,636 | $2.75 | $9,999 | 106,664 | Nov 22, 2024 |
| Nov 20, 2024 | Adam R. Levy Chief Executive Officer | POpen-market purchase Common Stock | +3,636 | $2.75 | $9,999 | 333,196 | Nov 22, 2024 |
| Nov 20, 2024 | Scott Robert Henry director | POpen-market purchase Common Stock | +1,818 | $2.75 | $5,000 | 147,553 | Nov 22, 2024 |
| Nov 20, 2024 | Adam E Drapczuk III Chief Financial Officer | POpen-market purchase Common Stockindirect: See Footnote | +17,500 | $2.75 | $48k | 74,894 | Nov 22, 2024 |
| Nov 20, 2024 | Scott Robert Henry director | AGrant or award Warrant to Purchase Common Stockderivative | +909 | $0.00 | $0 | 909 | Nov 22, 2024 |
| Nov 20, 2024 | Adam R. Levy Chief Executive Officer | AGrant or award Warrant to Purchase Common Stockderivative | +1,818 | $0.00 | $0 | 1,818 | Nov 22, 2024 |
| Nov 20, 2024 | Jerome B Zeldis director | AGrant or award Warrant to Purchase Common Stockderivative | +1,818 | $0.00 | $0 | 1,818 | Nov 22, 2024 |
| Nov 20, 2024 | John Nachum Stein director | POpen-market purchase Common Stock | +3,636 | $2.75 | $9,999 | 471,456 | Nov 22, 2024 |
| Nov 20, 2024 | steven mark glassman director | AGrant or award Warrant to Purchase Common Stockderivative | +4,545 | $0.00 | $0 | 4,545 | Nov 22, 2024 |
| Nov 20, 2024 | John Nachum Stein director | AGrant or award Warrant to Purchase Common Stockderivative | +1,818 | $0.00 | $0 | 1,818 | Nov 22, 2024 |
| Nov 20, 2024 | Adam E Drapczuk III Chief Financial Officer | AGrant or award Warrant to Purchase Common Stockderivativeindirect: See Footnote | +8,750 | $0.00 | $0 | 8,750 | Nov 22, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Adam E Drapczuk IIIChief Financial Officer
- Scott Robert Henrydirector
- Adam R. LevyChief Executive Officer
- John Nachum Steindirector
- Jerome B Zeldisdirector
- steven mark glassmandirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.